In this presentation, Dr. Daly discusses the recent FDA alert regarding biotin supplements interfering with immunoassay testing.  This can cause discrepancies particularly in endocrine testing.  In the face of laboratory immunoassay results that do not appear to reflect a true picture of the patient’s condition, question the patient about use of supplements containing biotin.

Click the image below to view this informative video that runs around 6 minutes.